RIPK3 and acute respiratory distress syndrome: The increase in plasma RIPK3 concentration in patients with ARDS 6 days before onset was significantly greater than that in patients without ARDS; the amount of change in plasma RIPK3 was also positively correlated with the 30-day mortality rate (27).